(EUFN) iShares MSCI Europe - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US4642891802 • Financial
EUFN: Banks, Insurance, Investments, Financial Services
The iShares MSCI Europe Financials ETF (NASDAQ: EUFN) is a targeted investment vehicle designed to track the performance of the financial sector across developed European markets. The fund adheres to a strict investment policy, allocating at least 80% of its assets to securities within its underlying index or to investments that mirror the economic characteristics of those securities. This ensures a high level of alignment with the indexs performance, making it a precise tool for investors seeking exposure to Europes financial sector.
The underlying index, the MSCI Europe Financials Index, is a free float-adjusted, market capitalization-weighted benchmark. It captures the collective equity performance of publicly traded financial companies in developed European markets. By focusing on market capitalization weighting, the index inherently allocates more weight to larger, more established financial institutions, which often have greater market influence and stability. The free float adjustment ensures that only the shares available for public trading are considered, aligning the index more closely with the actual investable market.
Domiciled in the United States, the ETF is listed on the NASDAQ exchange under the ticker symbol EUFN. This structure allows U.S. investors to gain exposure to European financial markets with the ease of trading a domestic security. The fund falls under the Financial category of ETFs, making it a niche product for investors seeking targeted sector exposure rather than broad market coverage.
With an AUM of $2.16 billion, EUFN is a sizeable fund, indicating significant investor interest and liquidity. Its expense ratio of 0.48% is competitive for a Europe-focused financial sector ETF, balancing cost efficiency with targeted exposure. The fund holds approximately 70 constituents, providing diversification across the European financial landscape while avoiding excessive concentration in any single company or region.
The ETFs portfolio spans a range of financial subsectors, including banking, insurance, and asset management. This diversification within the financial sector reduces reliance on any one area
Additional Sources for EUFN ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
EUFN ETF Overview
Market Cap in USD | 2,535m |
Category | Financial |
TER | 0.51% |
IPO / Inception | 2010-01-20 |
EUFN ETF Ratings
Growth 5y | 87.1% |
Fundamental | - |
Dividend | 72.6% |
Rel. Strength Industry | 12.7 |
Analysts | - |
Fair Price Momentum | 31.15 USD |
Fair Price DCF | - |
EUFN Dividends
Dividend Yield 12m | 4.80% |
Yield on Cost 5y | 10.64% |
Annual Growth 5y | 38.83% |
Payout Consistency | 89.7% |
EUFN Growth Ratios
Growth Correlation 3m | 85.9% |
Growth Correlation 12m | 88.2% |
Growth Correlation 5y | 85.9% |
CAGR 5y | 19.71% |
CAGR/Max DD 5y | 0.56 |
Sharpe Ratio 12m | 1.99 |
Alpha | 30.34 |
Beta | 0.63 |
Volatility | 16.17% |
Current Volume | 3443.4k |
Average Volume 20d | 1404.9k |
As of March 06, 2025, the stock is trading at USD 28.82 with a total of 3,443,400 shares traded.
Over the past week, the price has changed by +4.76%, over one month by +13.33%, over three months by +19.68% and over the past year by +42.31%.
Yes. Based on ValueRay Analyses, iShares MSCI Europe (NASDAQ:EUFN) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 87.14 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EUFN as of March 2025 is 31.15. This means that EUFN is currently overvalued and has a potential downside of 8.08%.
iShares MSCI Europe has no consensus analysts rating.
According to ValueRays Forecast Model, EUFN iShares MSCI Europe will be worth about 35.9 in March 2026. The stock is currently trading at 28.82. This means that the stock has a potential upside of +24.5%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 35.9 | 24.5% |